awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q41094757-3C60744A-ADCB-44E1-ACF2-BE2FFB26DC8E
Q41094757-3C60744A-ADCB-44E1-ACF2-BE2FFB26DC8E
BestRank
Statement
http://www.wikidata.org/entity/statement/Q41094757-3C60744A-ADCB-44E1-ACF2-BE2FFB26DC8E
Time-Dependent Prognostic Impact of Circulating Tumor Cells Detection in Non-Metastatic Breast Cancer: 70-Month Analysis of the REMAGUS02 Study.
P2860
Q41094757-3C60744A-ADCB-44E1-ACF2-BE2FFB26DC8E
BestRank
Statement
http://www.wikidata.org/entity/statement/Q41094757-3C60744A-ADCB-44E1-ACF2-BE2FFB26DC8E
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
27090b2496ce50b7af01da83f3bf7d45ce2be1b9
P2860
Neoadjuvant bevacizumab, trastuzumab, and chemotherapy for primary inflammatory HER2-positive breast cancer (BEVERLY-2): an open-label, single-arm phase 2 study.